Target intelligence / Profile preview

RNA, U6 small nuclear 399, pseudogene (RNU6-399P)

Target
RNU6-399P
Molecular classification
Pseudogene, Non-coding RNA (ncRNA, as part of U6 snRNA-related gene family)
01

Overview

RNU6-399P (RNA, U6 small nuclear 399, pseudogene) is a pseudogene, meaning it represents a nonfunctional segment of DNA that bears strong sequence similarity to the genuine U6 small nuclear RNA (snRNA) gene family but does not encode a functional product[2][7]. Pseudogenes like RNU6-399P are typically the result of gene duplication or retrotransposition events, and they are classified as "processed" or "unprocessed" depending on their genomic features[6]. Unlike the canonical U6 snRNA, which is an integral, functional RNA component of the spliceosome complex required for pre-mRNA splicing in eukaryotic cells[1][3], pseudogenes such as RNU6-399P lack the regulatory elements or sequence integrity required for transcription into a functional RNA. There is no evidence that RNU6-399P serves as a protein-coding gene, functional RNA, drug target, or has direct biological, pathological, or clinical significance[2][7]. The presence of U6 snRNA pseudogenes is common in vertebrate genomes and reflects evolutionary gene duplication and genome complexity[3][5][6]. Key points: - RNU6-399P is a pseudogene related to U6 snRNA. - It does not encode a functional RNA or protein, nor does it play a direct role in cellular function or disease[2][7]. - It is not considered a therapeutic target. - There are no known clinical or pharmacological implications. - The entry may be considered “incorrect” for therapeutic or target-focused applications, as it is nonfunctional and lacks biological activity[2][7]. If you were seeking information about the functional U6 snRNA: - The canonical functional gene is called "U6 small nuclear RNA" (often abbreviated as "RNU6" or "U6 snRNA"). - U6 snRNA is critical for splicing and spliceosome assembly, but RNU6-399P is only a nonfunctional, genomic byproduct related to this family[1][3].

Other names
RNU6-399PRNA, U6 small nuclear 399, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 399, pseudogene (RNU6-399P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 399, pseudogene (RNU6-399P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call